Literature DB >> 22720749

Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.

Alba Fiorentino1, Rocchina Caivano, Costanza Chiumento, Mariella Cozzolino, Vincenzo Fusco.   

Abstract

Glioblastoma (GBM) developed metastases rarely and the prognosis, in these cases, was very poor. We reported a 30-year patient who, developing intramedullary and leptomeningeal metastases from GBM, underwent palliative spinal radiotherapy (RT) and Bevacizumab.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22720749     DOI： 10.3109/00207454.2012.704456

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN： 0020-7454            Impact factor:   2.292


  5 in total

Review 1.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

2.  Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report.

Authors:  Yoshiko Okita; Masahiro Nonaka; Toru Umehara; Yonehiro Kanemura; Yoshinori Kodama; Masayuki Mano; Shin Nakajima
Journal:  Oncol Lett       Date:  2015-02-06       Impact factor: 2.967

3.  Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.

Authors:  Xun Kang; Feng Chen; Shou-Bo Yang; Ya-Li Wang; Zeng-Hui Qian; Yan Li; Hao Lin; Parker Li; Yi-Chen Peng; Xiao-Min Wang; Wen-Bin Li
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

4.  Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report.

Authors:  Thomas Linsenmann; Camelia M Monoranu; Giles H Vince; Thomas Westermaier; Carsten Hagemann; Almuth F Kessler; Ralf-Ingo Ernestus; Mario Löhr
Journal:  BMC Res Notes       Date:  2014-08-07

5.  Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

Authors:  Michael C Burger; Pia S Zeiner; Kolja Jahnke; Marlies Wagner; Michel Mittelbronn; Joachim P Steinbach
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.